ArticleFrontiers in endocrinology2026
Association between glycated hemoglobin A1c and diabetic retinopathy in adults with type 2 diabetes mellitus residing at high altitudes.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: To investigate the association between glycated hemoglobin A1c (HbA1c) and diabetic retinopathy (DR) in adults with type 2 diabetes mellitus (T2DM) at high altitude, and to explore potential effect modifiers. Methods: This retrospective, hospital-based, cross-sectional study included 1040 adults with T2DM residing at high altitude in Qinghai Province, stratified into two altitude groups (1800-2500 m vs. ≥2500 m); no low-altitude comparison group was included. DR was diagnosed by fundus photography. Logistic regression, restricted cubic spline analyses, stratified and interaction analyses were performed. Results: DR prevalence was 26.6% (n = 277). After full adjustment, each 1% increase in HbA1c was associated with higher odds of prevalent DR (OR 1.19, 95% CI 1.12-1.25), with no evidence of nonlinearity. Altitude did not significantly modify the association ( Conclusions: Among high-altitude adults with T2DM, HbA1c exhibited a linear positive association with prevalent DR; lower eGFR significantly modified this association, whereas the modifying trend linked to higher BMI remains exploratory and needs additional confirmation. These findings suggest that glycemic control, weight status, and renal function may need to be considered jointly when assessing DR burden in high-altitude populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.